WO2009000551A8 - Use of a synergistic composition as a therapeutic agent or disinfectant - Google Patents

Use of a synergistic composition as a therapeutic agent or disinfectant Download PDF

Info

Publication number
WO2009000551A8
WO2009000551A8 PCT/EP2008/005292 EP2008005292W WO2009000551A8 WO 2009000551 A8 WO2009000551 A8 WO 2009000551A8 EP 2008005292 W EP2008005292 W EP 2008005292W WO 2009000551 A8 WO2009000551 A8 WO 2009000551A8
Authority
WO
WIPO (PCT)
Prior art keywords
disinfectant
therapeutic agent
synergistic composition
composition
disinfecting
Prior art date
Application number
PCT/EP2008/005292
Other languages
German (de)
French (fr)
Other versions
WO2009000551A1 (en
Inventor
Barbara Krug
Sven Eggerstedt
Richard Bloss
Christiane Ostermeyer
Thomas Lisowsky
Karlheinz Esser
Frank Buerger
Original Assignee
Bode Chemie Gmbh
Multibind Biotec Gmbh
Barbara Krug
Sven Eggerstedt
Richard Bloss
Christiane Ostermeyer
Thomas Lisowsky
Karlheinz Esser
Frank Buerger
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bode Chemie Gmbh, Multibind Biotec Gmbh, Barbara Krug, Sven Eggerstedt, Richard Bloss, Christiane Ostermeyer, Thomas Lisowsky, Karlheinz Esser, Frank Buerger filed Critical Bode Chemie Gmbh
Priority to US12/452,295 priority Critical patent/US8557265B2/en
Priority to JP2010513766A priority patent/JP2010531320A/en
Priority to ES08773742T priority patent/ES2423730T3/en
Priority to CA002692341A priority patent/CA2692341A1/en
Priority to EP08773742.5A priority patent/EP2170398B1/en
Publication of WO2009000551A1 publication Critical patent/WO2009000551A1/en
Publication of WO2009000551A8 publication Critical patent/WO2009000551A8/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Abstract

The invention relates to the use of a composition comprising a vitamin, a metal ion, and a surfactant as a therapeutic agent or disinfectant. Said composition has been known as a decontaminant because the same efficiently decomposes DNA. It has now been possible to demonstrate that said agent has surprisingly good compatibility while having a wide-ranging disinfecting effect and is therefore also suitable for other purposes, e.g. for disinfecting or dressing wounds.
PCT/EP2008/005292 2007-06-28 2008-06-27 Use of a synergistic composition as a therapeutic agent or disinfectant WO2009000551A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US12/452,295 US8557265B2 (en) 2007-06-28 2008-06-27 Use of a synergistic composition as a therapeutic agent of disinfectant
JP2010513766A JP2010531320A (en) 2007-06-28 2008-06-27 Use of the synergistic composition as a therapeutic or disinfectant
ES08773742T ES2423730T3 (en) 2007-06-28 2008-06-27 Use of a synergistic composition as a therapeutic agent or disinfection agent
CA002692341A CA2692341A1 (en) 2007-06-28 2008-06-27 Use of a synergistic composition as a therapeutic agent or disinfectant
EP08773742.5A EP2170398B1 (en) 2007-06-28 2008-06-27 Use of a synergistic composition as a therapeutic agent or disinfectant

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007030103A DE102007030103A1 (en) 2007-06-28 2007-06-28 Use of a synergistic composition as a therapeutic or cosmetic agent
DE102007030103.2 2007-06-28

Publications (2)

Publication Number Publication Date
WO2009000551A1 WO2009000551A1 (en) 2008-12-31
WO2009000551A8 true WO2009000551A8 (en) 2009-07-23

Family

ID=39817047

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2008/005292 WO2009000551A1 (en) 2007-06-28 2008-06-27 Use of a synergistic composition as a therapeutic agent or disinfectant

Country Status (7)

Country Link
US (1) US8557265B2 (en)
EP (2) EP2489370A1 (en)
JP (1) JP2010531320A (en)
CA (1) CA2692341A1 (en)
DE (1) DE102007030103A1 (en)
ES (1) ES2423730T3 (en)
WO (1) WO2009000551A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005020327A1 (en) * 2005-04-30 2006-11-09 Multibind Biotec Gmbh Decontamination solutions and their use for denaturation, modification, degradation, solubilization and removal of proteins, nucleic acid molecules and microorganisms from surfaces
DE102008064481A1 (en) 2008-12-18 2010-08-12 Bode Chemie Gmbh Combined disinfectants and decontaminants with increased effectiveness
EP2481288A1 (en) 2011-01-26 2012-08-01 multiBIND biotec GmbH Synergistic disinfecting compositions with essential oils
DE102015113641A1 (en) 2015-08-18 2017-02-23 Bode Chemie Gmbh Disinfectant with organic acids
RU2743529C1 (en) * 2015-09-29 2021-02-19 Текуро Медикал Гмбх Stabilized antiseptic preparations
JP2020528084A (en) * 2017-07-20 2020-09-17 ゴメス − ロペス、ベンセスラオ Formulations containing nanostructured biocompatible and biocatalytic materials for the treatment of wounds and infections
MX2018002983A (en) * 2018-03-09 2019-09-10 Inst Tecnologico Jose Mario Molina Pasquel Y Henriquez Enhancing antiviral suspension for treatment of fibres and preparation method thereof.

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7007A (en) * 1850-01-08 Improvement in machinery for making cotton cordage
US3018A (en) * 1843-03-21 Coupling for qttilting-frames
FR2041M (en) 1962-04-17 1963-09-30 Andre Anselme Marie Therapeutic composition with cytotoxic properties based on ascorbic acid and metal ions.
EP0046409A1 (en) 1980-08-20 1982-02-24 Erwin Günther Walliczek A process for the preparation of a solution of a cuprous complex; solutions of the cuprous complexes for use in the therapeutic treatment of the human or animal body; and a method of therapeutic treatment of a plant
US5733572A (en) * 1989-12-22 1998-03-31 Imarx Pharmaceutical Corp. Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
WO1996003653A1 (en) * 1994-07-27 1996-02-08 Silica Gel Ges.Mbh Absorptionstechnik, Apparatebau Superparamagnetic particles, process for their production and their use
GB2292746A (en) * 1994-08-30 1996-03-06 John Peter Hugh Williamson Bleach compositions
JP3602141B2 (en) * 1996-01-31 2004-12-15 サウス、アラバマ、メディカル、サイエンス、ファウンデーション Food and vitamin preparations containing natural isomers of reduced folate
DE19603653B4 (en) 1996-02-01 2004-02-12 Siemens Ag Transmission stage, in particular for a remote-controlled theft protection system of a motor vehicle
JP3853985B2 (en) 1998-08-03 2006-12-06 有限会社 健康百二十才 Disinfectant containing iron ions
JP4727816B2 (en) * 1998-10-08 2011-07-20 エル． カラジョージアン、ハンパー Synergistic antibacterial dermatology / ophthalmic preparation containing chlorite and hydrogen peroxide
EP1154804B1 (en) * 1999-02-26 2008-02-20 Johnson & Johnson Consumer Companies, Inc. Bioadhesive antibacterial wound healing composition
DE50104383D1 (en) 2000-01-28 2004-12-09 Merck Patent Gmbh FORMULA CONTAINING BENZOFURANONE DERIVATIVES TO PROTECT AGAINST OXIDATIVE STRESS
JP2002104974A (en) * 2000-09-29 2002-04-10 Nichiban Co Ltd Hydrogel therapeutic agent for damaged skin
AU2000277429A1 (en) * 2000-09-29 2002-04-15 The Procter And Gamble Company Allergen neutralization compositions
US20030185915A1 (en) * 2002-03-28 2003-10-02 Jaime Carlo Synergetic composition for the treatment of psoriasis and other skin disorders and method therefor
GB0212405D0 (en) 2002-05-29 2002-07-10 Insignion Holdings Ltd Composition and its therapeutic use
JP4677192B2 (en) * 2004-02-20 2011-04-27 株式会社オゾテック Method for producing ozone-dissolved glycerin solution
US7115287B2 (en) 2005-03-03 2006-10-03 F.L.M., L.L.C. Topical medicament and method of use
DE102005020327A1 (en) * 2005-04-30 2006-11-09 Multibind Biotec Gmbh Decontamination solutions and their use for denaturation, modification, degradation, solubilization and removal of proteins, nucleic acid molecules and microorganisms from surfaces
DE102005044361A1 (en) 2005-09-09 2007-03-15 Aesculap Ag & Co. Kg Antimicrobial medical device product, process for its preparation and use
EP1940816A2 (en) 2005-09-30 2008-07-09 OMP, Inc. Stable ascorbic acid compositions
DE102006018983A1 (en) * 2006-04-25 2007-10-31 Multibind Biotec Gmbh Decontamination solution, useful for degrading, solubilizing and removing protein and nucleic acid molecule from a solution and surface e.g. culture medium, comprises a vitamin, a metal ion and a surface active compound
DE102006049108B4 (en) * 2006-10-13 2019-05-02 Agxx Intellectual Property Holding Gmbh Bioactive, ruthenium-containing coatings, their use and method of coating a device

Also Published As

Publication number Publication date
EP2170398B1 (en) 2013-05-15
US8557265B2 (en) 2013-10-15
EP2489370A1 (en) 2012-08-22
EP2170398A1 (en) 2010-04-07
US20100119566A1 (en) 2010-05-13
DE102007030103A1 (en) 2009-01-02
CA2692341A1 (en) 2008-12-31
ES2423730T3 (en) 2013-09-24
JP2010531320A (en) 2010-09-24
WO2009000551A1 (en) 2008-12-31

Similar Documents

Publication Publication Date Title
WO2010078883A3 (en) Combined disinfection and decontamination agent having increased effectivity
WO2007064931A3 (en) Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
WO2008070670A3 (en) Enhanced immediate release formulations of topiramate
WO2009000551A8 (en) Use of a synergistic composition as a therapeutic agent or disinfectant
WO2006096439A3 (en) Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases
WO2010127099A3 (en) Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
BRPI1007379B8 (en) pharmaceutical compositions for the treatment or prevention of oral infections by e. coli
WO2007068894A3 (en) Substituted diphenylethers, -amines, -sulfides and -methanes for the treatment of respiratory disease
WO2007011962A3 (en) Treatment of cancer
MY143795A (en) Tetrahydropyridoindole derivatives
TN2009000137A1 (en) Substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
WO2006074359A3 (en) Non-irritating compositions containing zinc salts
TW200738724A (en) Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
WO2006116221A3 (en) Therapeutic combinations for the treatment or prevention of psychotic disorders
WO2010111640A3 (en) Anti-influenza formulations and methods
WO2007121088A3 (en) Combinations of therapeutic agents for treating cancer
WO2010074936A3 (en) Enzastaurin for the treatment of cancer
HK1112721A1 (en) Tissue disruption treatment and composition for use thereof
WO2007123740A3 (en) Pharmaceutical compositions for promoting wound healing
HK1112228A1 (en) Substituted azachinzolines having an antiviral action
WO2006113718A3 (en) Compositions for the treatment of neoplasms
WO2011113000A8 (en) Novel ester containing compositions and methods
WO2011088209A3 (en) 1-deoxy analogs of vitamin d-related compounds
WO2004098522A3 (en) Gemini vitamin d3 compounds and methods of use thereof
WO2009092892A3 (en) Novel composition for treating the side effects of anticancer treatments

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08773742

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 12452295

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2010513766

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2692341

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2008773742

Country of ref document: EP